Acarix A/S (ACARIX) - Total Assets
Based on the latest financial reports, Acarix A/S (ACARIX) holds total assets worth Skr43.50 Million SEK (≈ $4.68 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Acarix A/S - Total Assets Trend (2014–2025)
This chart illustrates how Acarix A/S's total assets have evolved over time, based on quarterly financial data. Also see Acarix A/S market cap and net worth for the company's overall valuation and market capitalisation.
Acarix A/S - Asset Composition Analysis
Current Asset Composition (December 2025)
Acarix A/S's total assets of Skr43.50 Million consist of 85.8% current assets and 14.2% non-current assets. Review Acarix A/S debt and liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 37.8% |
| Accounts Receivable | Skr16.75 Million | 34.7% |
| Inventory | Skr6.46 Million | 13.4% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr6.47 Million | 13.4% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2014–2025)
This chart illustrates how Acarix A/S's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See ACARIX stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Acarix A/S's current assets represent 85.8% of total assets in 2025, a decrease from 88.4% in 2014.
- Cash Position: Cash and equivalents constituted 37.8% of total assets in 2025, down from 47.6% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 13.0% of total assets, an increase from 11.0% in 2014.
- Asset Diversification: The largest asset category is accounts receivable at 34.7% of total assets.
Acarix A/S Competitors by Total Assets
Key competitors of Acarix A/S based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.89 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.20 Billion |
|
Stratec SE
XETRA:SBS
|
Germany | €408.98 Million |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
DRTECH Corporation
KQ:214680
|
Korea | ₩235.84 Billion |
|
Novacyt
PA:ALNOV
|
France | €40.28 Million |
|
Diagnostic Medical Systems SA
PA:ALDMS
|
France | €62.52 Million |
Acarix A/S - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.72 | 11.59 | 7.77 |
| Quick Ratio | 4.77 | 10.26 | 7.12 |
| Cash Ratio | 0.00 | 9.33 | 6.68 |
| Working Capital | Skr30.91 Million | Skr51.14 Million | Skr39.65 Million |
Acarix A/S - Advanced Valuation Insights
This section examines the relationship between Acarix A/S's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.11 |
| Latest Market Cap to Assets Ratio | 0.55 |
| Asset Growth Rate (YoY) | -40.2% |
| Total Assets | Skr48.33 Million |
| Market Capitalization | $26.71 Million USD |
Valuation Analysis
Below Book Valuation: The market values Acarix A/S's assets below their book value (0.55x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Acarix A/S's assets decreased by 40.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Acarix A/S (2014–2025)
The table below shows the annual total assets of Acarix A/S from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr48.33 Million ≈ $5.20 Million |
-40.16% |
| 2024-12-31 | Skr80.76 Million ≈ $8.69 Million |
+28.43% |
| 2023-12-31 | Skr62.88 Million ≈ $6.77 Million |
-9.49% |
| 2022-12-31 | Skr69.48 Million ≈ $7.48 Million |
-41.42% |
| 2021-12-31 | Skr118.60 Million ≈ $12.76 Million |
+31.86% |
| 2020-12-31 | Skr89.95 Million ≈ $9.68 Million |
+8.39% |
| 2019-12-31 | Skr82.98 Million ≈ $8.93 Million |
-12.83% |
| 2018-12-31 | Skr95.20 Million ≈ $10.24 Million |
-28.99% |
| 2017-12-31 | Skr134.06 Million ≈ $14.43 Million |
-22.64% |
| 2016-12-31 | Skr173.29 Million ≈ $18.65 Million |
+1012.09% |
| 2015-12-31 | Skr15.58 Million ≈ $1.68 Million |
-14.78% |
| 2014-12-31 | Skr18.28 Million ≈ $1.97 Million |
-- |
About Acarix A/S
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to support clinical decision making at the point of care. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Au… Read more